Kirk Allan has filed 5 insider transactions across 1 company since October 2023.
Most recent transaction: a option exercise of 3430 shares of Eledon Pharmaceuticals, Inc. ($ELDN) on January 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2026 | Eledon Pharmaceuticals, Inc. | $ELDN | Kirk Allan | Not found | M | Common Stock | 3430 | $0.00 | 3,430.0000 | 77,156,068 | 9999.99% | 0.00% |
| Jan. 10, 2026 | Eledon Pharmaceuticals, Inc. | $ELDN | Kirk Allan | Not found | M | Restricted Stock Units | 3430 | $0.00 | 0.0000 | 77,156,068 | 100.00% | 0.00% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Kirk Allan | Not found | A | Stock Option (right to buy) | 30870 | $0.00 | 30,870.0000 | 48,543,787 | 9999.99% | 0.06% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Kirk Allan | Not found | A | Restricted Stock Units | 3430 | $0.00 | 3,430.0000 | 48,543,787 | 9999.99% | 0.01% |
| Oct. 2, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Kirk Allan | Director | A | Stock Option (Right to Buy) | 150437 | $1.55 | 150,437.0000 | 0 | 9999.99% | 0.00% |